Regulation of Cellular Behavior in Response to Extracellular Cues
Project Number3P20GM144265-01A1S1
Former Number1P20GM144265-01A1
Contact PI/Project LeaderHENRY, CLARISSA A
Awardee OrganizationUNIVERSITY OF MAINE ORONO
Description
Abstract Text
PROJECT SUMMARY
COBRE - 1P20GM144265-01
Parent award goal:
The parent award goal is the COBRE Center for the Regulation of Cellular Behavior in
Response to Extracellular Cues. This COBRE grant supports 5 junior project leaders from University
of Maine (UMaine) and Mount Desert Island Biological Laboratory (MDIBL). The parent award builds
organizational structure to run essential research programs and help grow the research community
around cohesive common research themes. Research projects funded through the COBRE center for
the Regulation of Cellular Behavior in Response to Extracellular Cues will significantly develop our
understanding and knowledge regarding the physiological and pathophysiological roles of external
stimuli (such as cell-cell communication, signaling pathway, or viral infection) during development,
regeneration, health or diseases.
Supplement award goal:
Title: Proteostasis, atrophy and degeneration in the context of muscle aging
Sarcopenia is a multifactorial disease characterized by the loss of muscle mass, strength and
function. Associated with aging and age-related diseases, it is a major issue negatively affecting quality
of life and the rising cost of health care. The problem with sarcopenia is two-fold: there is a loss of
proteostatic maintenance leading to degeneration of muscle fibers as well as a lack of ability to
regenerate healthy tissue. During aging, muscle wasting is associated with increased expression of the
striated muscle-specific protein turnover factor Atrogin-1. The Madelaine lab found that overexpression
of this factor in zebrafish leads to rapid degeneration of muscle fibers, atrophic muscle tissue and
locomotor dysfunctions. Surprinsigly, the expression of this factor is also increased under dietary
restriction (DR) involving fasting. DR is the most robust aging intervention to increase healthy lifespan
and preserve long-term muscle maintenance. As metabolic parameters are reset to match dietary
limitations, adaptation to DR temporarily induces muscle catabolism associated with increased atrogin-
1. Interestingly, the Atrogin-1 protein appears to have a central role in proteostasis and muscle
homeostatis in the context of both health and disease. Understanding how Atrogin-1 and associated
factors regulate muscle proteostasis in different contexts may help in the development of therapeutic
approaches to limit muscle atrophy and ameliorate muscle wasting. However, use of vertebrate systems
like mice for investigating skeletal muscle wasting in the context of natural aging require several years
and comes at great cost. Use of a alternative vertebrate model organisms would allow genetic and
environmental interventions at a reduced cost and within a relatively short period of time.
The zebrafish is a well established powerful organism for genetic manipulations and modeling of
human diseases, while Nothobranchius furzeri (N. furzeri) has recently emerged as a model for
investigating both aging and regeneration. N. furzeri is the shortest-lived vertebrate bred in captivity,
living only a few months. We propose to use these fish models to investigate muscle maintenance
associated with changes in proteostasis and regenerative capacity during aging and/or DR. The
Madelaine lab has established a new genetic model of accelerated muscle aging in zebrafish that we will
use to leverage modifications associated with increase muscle degeneration and atrophy. The Rogers
lab has developed a model of dietary restriction (DR) involving intermittent fasting in N. furzeri that works
to increase healthy lifespan in male and female animals. This provides an intervention strategy to mitigate
loss of proteostasis and regenerative capacity that occur with age. These different experimental
conditions also allows for comparison of the positive role of Atrogin-1 in adaptation to DR with its
pathological role in sarcopenia. In order to generate data required to better understand cellular changes
associated with muscle aging and to support future grant applications, we want to establish a substantive
collaborative effort on the part of our labs. We propose to carry out the following research goals: 1) Test
locomotion and swimming performance to determine muscle function in fish models of accelerated
muscle aging and after fasting. 2) Assess muscle structural integrity using tissue-clearing and light-sheet
imaging in a genetic model of sarcopenia, during aging and under DR. 3) Use a single cell multiomics
approach to characterize changes in muscle proteostatic maintenance associated with expression of
Atrogin-1, aging and under DR.
This supplement award project fits in the scope of the parent award with the objective to identify
molecular effectors of muscle aging and cellular changes within the muscle tissue associated with
genetic and dietary interventions. The collaborative effort from two labs with complementary technical
skills and expertise (accelerated muscle aging and lifespan/healthspan intervention) will strengthen the
outcome of this research project.
Public Health Relevance Statement
Over the last century, progress in medicine and biomedical research has significantly increased
the human lifespan. Unfortunately, the number of people suffering from age-related diseases
has also increased drama=cally. A serious impediment to quality of life is age-associated
degenera=ve loss of muscle leading to muscular atrophy, or sarcopenia. The overall goal of this
proposal is to leverage gene=c and dietary interven=ons to iden=fy molecular and cellular
mechanisms underlying dysregula=on of proteostasis and onset of muscle atrophy during aging.
No Sub Projects information available for 3P20GM144265-01A1S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3P20GM144265-01A1S1
Patents
No Patents information available for 3P20GM144265-01A1S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3P20GM144265-01A1S1
Clinical Studies
No Clinical Studies information available for 3P20GM144265-01A1S1
News and More
Related News Releases
No news release information available for 3P20GM144265-01A1S1
History
No Historical information available for 3P20GM144265-01A1S1
Similar Projects
No Similar Projects information available for 3P20GM144265-01A1S1